AUPH: Aurinia Pharmaceuticals Inc Sotuvga nisbatan narx

Aurinia Pharmaceuticals Inc (AUPH) kompaniyasining korporativ logotipi

Aurinia Pharmaceuticals (AUPH) Lupkynis bilan ta'sirchan lupus nefriti terapiyasida birinchi bo'lib kirganligi sababli narxlarni belgilashda ustunlikka ega. Kompaniyaning P/S koeffitsiyenti ushbu aktivning bozor qiymatini aniq ko'rsatadi, bunda 6.60 joriy darajani belgilaydi. Strategiya immunologiyada og'iz orqali qabul qilinadigan standart parvarishni joriy etishga asoslangan. Moliyaviy barqarorlik, yangi bemorlarni jalb qilish sur'atiga bog'liqlikka qaramay, kuchli likvidlikka tayanadi.

Kapitalizatsiyaning daromadga nisbati: Aurinia Pharmaceuticals (AUPH) 04.07.2022 - 16.11.2026 uchun

auriniapharma.com (AUPH) kompaniyasining tahliliy kesimlari

- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning fundamental tahlili:Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals tayyor mahsulotlari

Aurinia Pharmaceuticals (AUPH) xalqaro pharmacy hublarining diversifikatsiyalashgan tarmog'i orqali autoimmun patologiyalar terapiyasi uchun yuqori tannarxli dori vositalarining yetkazib berilishini ta'minlaydi. P/S vaqtlar ketma-ketligini tahlil qilish orqali investor bozor kapitalizatsiyasini haqiqiy daromadlar bilan solishtiradi, bu esa biznes qiymatini savdo hajmi bilan nisbatan real vaqt rejimida baholash imkonini beradi hamda joriy narxning past baholanganini yoki yashirin operatsion risklarni aks ettirayotganini aniqlaydi.

Raqobatdosh kompaniyalar

argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Kapitalizatsiyaning daromadga nisbati biocryst.com BCRX|Vera Therapeutics - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV - P/S multiplikatori|ABCL: Narxning daromadga nisbati|Tourmaline Bio, Inc. (TRML) - Narxning daromadga nisbati|Sotuvga nisbatan narx precigen.com (PGEN)|PHAR (pharming.com) - P/S multiplikatori|NKTR (Nektar Therapeutics Inc.) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori UPB|ZBIO - Sotuvga nisbatan narx|P/S multiplikatori IMNM (immunome.com)|Gossamer Bio, Inc. - Narxning daromadga nisbati|KalVista Pharmaceuticals, Inc. - P/S multiplikatori|SEPN (Septerna) - Kapitalizatsiya va daromad nisbati|Pieris Corp (PVLA) - Narxning daromadga nisbati|SVRA - Narx/daromad koeffitsiyenti|RIGL (rigel.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANAB (AnaptysBio, Inc.)|P/S multiplikatori ATXS|enGene Holdings Inc (ENGN) - Narx/daromad multiplikatori|P/S multiplikatori RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Narxning sotuvga nisbati|ACRS: Kapitalizatsiyaning daromadga nisbati|KYTX - P/S multiplikatori|TLSA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Cabaletta Bio, Inc|Narxning daromadga nisbati Ventyx Biosciences, Inc|THTX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati AVTX (Avalo Therapeutics, Inc)|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals ELDN|Narxning daromadga nisbati Agenus, Inc. AGEN|P/S multiplikatori Climb Bio Inc. CLYM|ZURA - Narxning daromadga nisbati|Narxning sotuvga nisbati ATYR|ADAG (Adagene Inc.) - Kapitalizatsiyaning daromadga nisbati|ImageneBio Inc (IMA) - P/S multiplikatori|Narxning daromadga nisbati Shattuck Therapeutics|Kapitalizatsiyaning daromadga nisbati equilliumbio.com (EQ)|P/S multiplikatori CNTB|Narx/daromad koeffitsiyenti Immunic Therapeutics|P/S multiplikatori ATRA (Atara Biotherapeutics, Inc.)|IFRX - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Kapitalizatsiya va daromad nisbati|CELU: P/S multiplikatori|INMB - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Barinthus Biotherapeutics plc|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|AKTX (Akari Therapeutics Plc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|edesabiotech.com (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori